PubRank

Mary Carrington

Author PubWeight™ 308.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006 15.63
2 Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009 13.99
3 The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010 9.61
4 HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004 8.22
5 Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002 7.58
6 Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007 6.83
7 The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 2006 4.26
8 Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis 2012 4.24
9 Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009 4.22
10 HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 2006 4.19
11 Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007 4.14
12 HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011 3.93
13 Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004 3.87
14 Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009 3.68
15 Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 2007 3.61
16 Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 2010 3.57
17 Influence of HLA-C expression level on HIV control. Science 2013 3.27
18 Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008 3.24
19 Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 2005 3.23
20 HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 2009 3.03
21 AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005 2.97
22 Host determinants of HIV-1 control in African Americans. J Infect Dis 2010 2.90
23 Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet 2006 2.80
24 The Yin and Yang of HLA and KIR in human disease. Semin Immunol 2008 2.72
25 High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet 2002 2.71
26 The shaping of modern human immune systems by multiregional admixture with archaic humans. Science 2011 2.63
27 HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011 2.59
28 Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol 2009 2.51
29 The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006 2.43
30 Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007 2.40
31 Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc Natl Acad Sci U S A 2011 2.37
32 Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011 2.36
33 An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 2003 2.29
34 Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007 2.28
35 Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010 2.19
36 KIR and disease: a model system or system of models? Immunol Rev 2006 2.07
37 KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2006 2.06
38 DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A 2007 2.04
39 HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol 2009 2.03
40 Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 2004 2.00
41 Next-generation sequencing for HLA typing of class I loci. BMC Genomics 2011 1.99
42 Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002 1.95
43 Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002 1.93
44 Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004 1.83
45 HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002 1.83
46 Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 2013 1.82
47 Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. J Virol 2007 1.81
48 High HLA-DP Expression and Graft-versus-Host Disease. N Engl J Med 2015 1.74
49 Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol 2008 1.73
50 CCL3L1 and HIV/AIDS susceptibility. Nat Med 2009 1.73
51 DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med 2003 1.70
52 HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol 2011 1.66
53 Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J Infect Dis 2006 1.62
54 Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008 1.60
55 Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc Natl Acad Sci U S A 2002 1.59
56 Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 2002 1.58
57 Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 2010 1.56
58 Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res 2005 1.56
59 Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet 2013 1.55
60 Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003 1.52
61 Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 2008 1.52
62 Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 2010 1.51
63 IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis 2010 1.48
64 Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2009 1.46
65 Cutting edge: expansion of the KIR locus by unequal crossing over. J Immunol 2003 1.46
66 The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers. J Virol 2007 1.46
67 Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 2011 1.44
68 Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis 2006 1.42
69 Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007 1.41
70 KIR locus polymorphisms: genotyping and disease association analysis. Methods Mol Biol 2008 1.41
71 Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006 1.39
72 MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci Transl Med 2010 1.38
73 Immunogenetics of viral infections. Curr Opin Immunol 2005 1.33
74 HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr 2002 1.33
75 Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog 2013 1.33
76 Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis 2008 1.30
77 Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol 2007 1.29
78 Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol 2012 1.29
79 Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes. J Virol 2002 1.28
80 Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 2010 1.28
81 Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol 2011 1.26
82 Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol 2008 1.25
83 Immunogenetics of HIV disease. Immunol Rev 2013 1.25
84 A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 2012 1.24
85 Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res Hum Retroviruses 2007 1.23
86 Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 2008 1.22
87 HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med 2009 1.22
88 Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum Mol Genet 2009 1.21
89 HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703. J Immunol 2011 1.18
90 Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore) 2005 1.18
91 Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol 2006 1.17
92 Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control. Nat Med 2013 1.17
93 HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS 2010 1.17
94 Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics 2003 1.16
95 KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif. PLoS Pathog 2011 1.14
96 The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis 2011 1.13
97 Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol 2008 1.13
98 Determinants of protection among HIV‐exposed seronegative persons: an overview. J Infect Dis 2010 1.13
99 Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 2004 1.12
100 Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet 2012 1.10
101 Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis 2008 1.07
102 The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. Am J Hum Genet 2011 1.06
103 A novel system of polymorphic and diverse NK cell receptors in primates. PLoS Genet 2009 1.06
104 A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet 2013 1.05
105 Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. J Infect Dis 2013 1.04
106 Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A 2013 1.04
107 Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2005 1.03
108 KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog 2011 1.02
109 Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. Clin Infect Dis 2009 1.02
110 KIR genotyping by multiplex PCR-SSP. Methods Mol Biol 2010 1.01
111 HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog 2012 1.01
112 Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Res Hum Retroviruses 2002 1.01
113 Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 2003 1.00
114 HIV control through a single nucleotide on the HLA-B locus. J Virol 2012 1.00
115 HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 2006 1.00
116 Identification of the ancestral killer immunoglobulin-like receptor gene in primates. BMC Genomics 2006 0.99
117 Counteraction of HLA-C-mediated immune control of HIV-1 by Nef. J Virol 2010 0.99
118 Novel member of the CD209 (DC-SIGN) gene family in primates. J Virol 2003 0.99
119 Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J Infect Dis 2011 0.98
120 Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr 2004 0.98
121 Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS 2012 0.98
122 The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet 2012 0.98
123 Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics 2013 0.98
124 HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics 2010 0.97
125 Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2003 0.97
126 Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course. J Acquir Immune Defic Syndr 2008 0.96
127 Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia. J Infect Dis 2003 0.95
128 Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study. AIDS 2014 0.94
129 Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J Immunol 2011 0.94
130 HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples. AIDS 2007 0.94
131 The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe 2009 0.92
132 Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol 2006 0.92
133 Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial. J Infect Dis 2011 0.91
134 HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood 2002 0.91
135 Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy. J Virol 2011 0.91
136 HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent. J Virol 2012 0.90
137 Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users. AIDS 2010 0.89
138 Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. Hum Immunol 2006 0.89
139 Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol 2009 0.89
140 Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function. AIDS 2014 0.89
141 Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India. J Infect Dis 2011 0.88
142 Host factors associated with outcome from primary human immunodeficiency virus-1 infection. Curr Opin HIV AIDS 2008 0.88
143 Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. Immunogenetics 2013 0.88
144 Host genetics of HIV acquisition and viral control. Annu Rev Med 2012 0.87
145 Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa. J Virol 2010 0.87
146 A mutation in KIR3DS1 that results in truncation and lack of cell surface expression. Immunogenetics 2007 0.86
147 Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin. Virology 2007 0.85
148 Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population. Cell Host Microbe 2009 0.85
149 HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN). J Biol Chem 2009 0.85
150 High-density map of short tandem repeats across the human major histocompatibility complex. Immunogenetics 2003 0.85
151 Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett 2005 0.85
152 Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease. J Infect Dis 2013 0.85
153 Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection. J Virol 2012 0.84
154 Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503. Immunogenetics 2009 0.84
155 Host genetic determinants of HIV pathogenesis: an immunologic perspective. Curr Opin HIV AIDS 2008 0.84
156 Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level. Cell Immunol 2005 0.83
157 A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Virology 2009 0.82
158 Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B. J Immunol 2008 0.82
159 Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon. AIDS 2007 0.81
160 Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology 2013 0.81
161 Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. Cancer Epidemiol Biomarkers Prev 2002 0.80
162 Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer 2007 0.80
163 Antibodies to varicella-zoster virus in blood donors with genetic variance in CC chemokine receptor 5. Lancet 2002 0.79
164 Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission. J Infect Dis 2010 0.79
165 Early immune adaptation in HIV-1 revealed by population-level approaches. Retrovirology 2014 0.79
166 Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial. PLoS One 2012 0.78
167 Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations. Immunogenetics 2010 0.78
168 Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica. J Infect Dis 2002 0.78
169 Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1. AIDS 2011 0.77
170 Response to Comment on "Influence of HLA-C expression level on HIV control". Science 2013 0.77
171 Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men. J Acquir Immune Defic Syndr 2004 0.76
172 The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men'. J Reprod Immunol 2006 0.75
173 Characterization of the HLA-C*07:01:01G allele group in European and African-American cohorts. Hum Immunol 2012 0.75
174 Antiviral synergism. Nat Genet 2005 0.75
175 Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry. Cancer Epidemiol Biomarkers Prev 2007 0.75
176 Natural killer cells and HIV-1 disease. Curr Opin HIV AIDS 2006 0.75